ICCB280

CAS No. 2041072-41-5

ICCB280 ( —— )

Catalog No. M23912 CAS No. 2041072-41-5

ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 97 In Stock
5MG 160 In Stock
10MG 290 In Stock
25MG 470 In Stock
50MG 683 In Stock
100MG 954 In Stock
500MG 1917 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ICCB280
  • Note
    Research use only, not for human use.
  • Brief Description
    ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
  • Description
    ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    C/EBPα
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2041072-41-5
  • Formula Weight
    386.4
  • Molecular Formula
    C23H18N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:85mg/mL (219.98mM)
  • SMILES
    O=C1N(C2=CC=CC=C2OC)C(/C=C/C3=CC=C(O)C(O)=C3)=NC4=C1C=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Radomska HS, Jernigan F, Nakayama S, et al. A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation. J Biomol Screen. 2015;20(9):1150-1159. doi:10.1177/1087057115592220
molnova catalog
related products